A recent study found that new solid lung nodules identified post-baseline may increase a patient’s risk of developing lung cancer. READ MORE

Conferences

One assay test reveals statistically lower levels of PD-L1 expression than the others.

READ MORE

Results show that hypofractionated radiation therapy may be a better treatment option for patients with non-small cell lung cancer.

READ MORE

Using a web application developed by French researchers may help clinicans to better manage follow-up for patients with lung cancer.

READ MORE

News

A recent study found that new solid lung nodules identified post-baseline may increase a patient’s risk of developing lung cancer.

READ MORE

A recent study compared the effectiveness of stereotactic ablative body radiotherapy with conventional full fractionated radiotherapy in prolonging time to local failure in patients with inoperable stage I non-small cell lung cancer.

READ MORE

Despite the majority of radiation oncologists administering the NCCN guideline-recommended thoracic radiotherapy schedule to patients with small-cell lung cancer, great variability still exists in dosing and fractionation.

READ MORE

A liquid biopsy that measures circulating lung tumor DNA at the end of treatment identifies patients with early NSCLC with a poor prognosis.

READ MORE

Research in Review

Increasing the standard dose of an ALK inhibitor for the treatment of NSCLC improves objective response rates by 9% with limited additional toxicity.

READ MORE

According to recent research published in the International Journal of Radiation Oncology, which form of therapy is effective in older patients with early stage lung cancer?

READ MORE

Stereotactic body radiation therapy is a safe treatment for patients aged 80 years or older with early-stage lung cancer.

READ MORE

Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows.

READ MORE

Resources

The International Association for the Study of Lung Cancer has published its first version of the Atlas of EGFR Testing in Lung Cancer.

READ MORE